BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7530531)

  • 1. [Regulation of prostatic growth, pathogenesis of prostatic adenoma and cancer].
    Darenkov AF; Evdokimov VV; Alfimov AE
    Vestn Ross Akad Med Nauk; 1994; (11):50-9. PubMed ID: 7530531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].
    Kinoshita H; Habuchi T; Ogawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():23-7. PubMed ID: 12599539
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
    Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG
    Urologiia; 2015; (3):50-4. PubMed ID: 26390560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia].
    Tørring N; Nexø E
    Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pathology of benign prostatic hyperplasia and prostate cancer.
    Maini A; Archer C; Wang CY; Haas GP
    In Vivo; 1997; 11(4):293-9. PubMed ID: 9292295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate].
    Chibichyan MB; Chernogubova EA; Avetyan AV; Lapteva TO; Pavlenko IA; Kogan MI
    Urologiia; 2022 Mar; (1):5-10. PubMed ID: 35274851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostatic growth and function by peptide growth factors.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
    Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].
    Desgrandchamps F; Tatoud R; Cussenot O; Teillac P; Le Duc A
    Prog Urol; 1992 Dec; 2(6):1031-44. PubMed ID: 1284554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign prostatic hyperplasia and growth factors: mechanisms and hypotheses].
    Aumüller G
    Urologe A; 1992 May; 31(3):159-65. PubMed ID: 1377433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Benign hyperplasia and cancer of the prostate.
    Br Med J; 1975 Jan; 1(5948):2-3. PubMed ID: 47254
    [No Abstract]   [Full Text] [Related]  

  • 16. Common characteristics of human and canine benign prostatic hyperplasia.
    Isaacs JT
    Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
    [No Abstract]   [Full Text] [Related]  

  • 17. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
    Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factors in the prostate.
    Matuo Y; Nishi N; Wada F
    Arch Androl; 1987; 19(3):193-210. PubMed ID: 2461175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of peptide growth factors in the prostate: a review.
    Steiner MS
    Urology; 1993 Jul; 42(1):99-110. PubMed ID: 7687082
    [No Abstract]   [Full Text] [Related]  

  • 20. Anatomy of the prostate: insight into benign prostatic hyperplasia anatomy and pathogenesis.
    Villers A
    Prog Clin Biol Res; 1994; 386():21-30. PubMed ID: 7528390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.